A Multicenter, Open-label, Randomized, Prospective Clinical Study of Adebrelimab Consolidation Therapy for Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Without Progression After Concurrent Chemoradiotherapy
Clinical trial NCT07559786 · RECRUITING
Trial details
- NCT number
- NCT07559786
- Sponsor
- Henan Cancer Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-17
- Primary completion
- 2029-07-17
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.